
Rankinidine
CAS No. 106466-66-4
Rankinidine( —— )
Catalog No. M21811 CAS No. 106466-66-4
Rankinidine is an oxindole alkaloid that is isolated from the MeOH extract of the stem of Gelsemium rankinii.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 1040 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameRankinidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRankinidine is an oxindole alkaloid that is isolated from the MeOH extract of the stem of Gelsemium rankinii.
-
DescriptionRankinidine is an oxindole alkaloid that is isolated from the MeOH extract of the stem of Gelsemium rankinii.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106466-66-4
-
Formula Weight340.42
-
Molecular FormulaC??H??N?O?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1[C@]2([C@H]3C[C@]4([H])[C@@](CO3)([H])[C@@H](NC/C4=C\C)C2)C5=CC=CC=C5N1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schun Y, et, al. Rankinidine, a new indole alkaloid from Gelsemium rankinii. J Nat Prod. Sep-Oct 1986; 49(5): 806-8.
molnova catalog



related products
-
lorvotuzumab
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.
-
Sphingosine (d17:1)
Sphingosine (d17:1) (C17 Sphingosine) is a 17-carbon sphingolipid found in human skin that can be phosphorylated by sphingomyelin kinase.Sphingosine C-17 can be used as an internal standard to perform spectroscopic analysis of sphingolipids.
-
Quercetin 3-O-(6-gal...
Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside can effectively induce apoptosis via p53, MAPKs and the mitochondrial apoptotic pathways.